- ¥3bn
- ¥3bn
- ¥9bn
- 48
- 67
- 37
- 49
Annual income statement for Lihit Lab, fiscal year end - February 29th, JPY millions except per share, conversion factor applied.
2020 February 29th | 2021 February 28th | 2022 February 28th | 2023 February 28th | 2024 February 29th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
| Standards: | JAS | JAS | JAS | JAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 9,816 | 8,565 | 8,693 | 8,514 | 8,803 |
| Cost of Revenue | |||||
| Gross Profit | 3,384 | 3,023 | 2,903 | 2,504 | 2,524 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 9,324 | 8,066 | 8,350 | 8,669 | 9,083 |
| Operating Profit | 492 | 499 | 343 | -155 | -279 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 484 | 503 | 407 | -32.2 | -119 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 337 | 353 | 263 | -24.4 | -93.7 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 337 | 353 | 263 | -24.4 | -93.7 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 337 | 353 | 263 | -24.4 | -93.7 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 101 | 104 | 77.6 | -6.87 | -27.6 |
| Dividends per Share |